Insider Trading activities of Vitae Pharmaceuticals, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vitae Pharmaceuticals, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vitae Pharmaceuticals, Inc since year 2005. Table 2 shows the detailed insider transactions of Vitae Pharmaceuticals, Inc since 2005. The reporting company's ticker symbol is VTAE. The reporting company's CIK number is 1157602.
The total value of stock buying since 2005 is $24,617,846.
The total value of stock sales since 2005 is $23,719,091.
The total value of stock option exercises since 2005 is $1,988,662.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Vitae Pharmaceuticals, Inc (VTAE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-10 0 $0 0 $0 123,902 $1,050,688
2016-09 0 $0 1,075,000 $22,411,749 0 $0
2016-03 0 $0 16,130 $119,684 16,130 $55,648
2015-12 0 $0 38,654 $673,248 65,191 $224,907
2015-11 0 $0 0 $0 100,557 $478,478
2015-09 0 $0 16,130 $274,210 16,130 $55,648
2015-08 10,000 $78,270 0 $0 0 $0
2015-05 0 $0 20,000 $240,200 20,000 $69,000
2015-03 0 $0 0 $0 8,115 $9,332
2015-01 0 $0 0 $0 39,097 $44,961
2014-09 3,067,447 $24,539,576 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Vitae Pharmaceuticals, Inc insiders (VTAE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-10-19 Gregg Richard (Chief Science Officer) Option Ex 123,902 8.48 1,050,688
2016-09-14 Hatfield Jeffrey S. (Chief Executive Officer) Sale 50,000 20.81 1,040,499
2016-09-14 Gross Phillip Sale 1,025,000 20.85 21,371,250
2016-03-21 Hayden Donald J Jr (Director) Sale 16,130 7.42 119,684
2016-03-21 Hayden Donald J Jr (Director) Option Ex 16,130 3.45 55,648
2015-12-29 Hayden Donald J Jr (Director) Sale 16,130 18.00 290,340
2015-12-29 Hayden Donald J Jr (Director) Option Ex 16,130 3.45 55,648
2015-12-28 Hatfield Jeffrey S. (Chief Executive Officer) Option Ex 26,537 3.45 91,552
2015-12-23 Hatfield Jeffrey S. (Chief Executive Officer) Sale 22,524 17.00 382,908
2015-12-23 Hatfield Jeffrey S. (Chief Executive Officer) Option Ex 22,524 3.45 77,707
2015-11-16 Gregg Richard (Chief Science Officer) Option Ex 15,000 3.91 58,650
2015-11-13 Gregg Richard (Chief Science Officer) Option Ex 85,557 4.91 419,828
2015-09-21 Hayden Donald J Jr (Director) Sale 16,130 17.00 274,210
2015-09-21 Hayden Donald J Jr (Director) Option Ex 16,130 3.45 55,648
2015-08-27 Fratamico Arthur (Chief Business Officer) Buy 10,000 7.83 78,270
2015-05-20 Hayden Donald J Jr (Director) Sale 20,000 12.01 240,200
2015-05-20 Hayden Donald J Jr (Director) Option Ex 20,000 3.45 69,000
2015-03-06 Hatfield Jeffrey S. (Chief Executive Officer) Option Ex 8,115 1.15 9,332
2015-01-22 Hatfield Jeffrey S. (Chief Executive Officer) Option Ex 39,097 1.15 44,961
2014-09-29 Barrett Peter (Director) Buy 37,500 8.00 300,000
2014-09-29 Vef Management Iii Llc (10% Owner) Buy 772,333 8.00 6,178,664
2014-09-29 Roberts Bryan E (Director) Buy 772,333 8.00 6,178,664
2014-09-29 Sandell Scott D (10% Owner) Buy 813,474 8.00 6,507,792
2014-09-29 Prospect Venture Partners Ii Lp (10% Owner) Buy 671,807 8.00 5,374,456

Insider trading activities including stock purchases, stock sales, and option exercises of VTAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vitae Pharmaceuticals, Inc (symbol VTAE, CIK number 1157602) see the Securities and Exchange Commission (SEC) website.